To investigate whether AXL and c-ABL expression levels are linked to clinicopathological features in EAC, we analyzed our data that included AXL and c-ABL protein expression in tumor samples and their corresponding clinicopathological information from 53 EAC patients (Supplemental Table S2). The gene discussed is AXL; the disease is neoplasm.